Skip to main content
Fig. 5 | Breast Cancer Research

Fig. 5

From: Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

Fig. 5

Global gene expression changes induced by each arm from baseline to surgery. a Heatmaps showing differential expression of 49 selected genes and gene signatures at 3 weeks in each arm. b 360° view summarizing the gene/signatures for the breast tumor microenvironment and immune response in LTZ+mVNB arm between baseline and surgery. c Venn diagram showing the overlap in the list of differentially expressed genes obtained in the before and after treatment across the comparisons of the three arms

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us